Recreating the Endocrine Niche: Advances in Bioengineering the Pancreas
Artificial Organs · 2025
DOI: 10.1111/aor.14950 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Artificial Organs, 2025. Verfasst von Laura Mar Fonseca und 3 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Tissue Engineering and Organ Regeneration, Department of Surgery, University of Geneva, Geneva, Switzerland. Hauptthemen laut MEDLINE: Islets of Langerhans Transplantation, Tissue Engineering, Islets of Langerhans, Diabetes Mellitus, Type 1. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 149 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung, Breakthrough T1D International, Horizon 2020 Framework Programme.
Abstract (Originalsprache)
Intrahepatic islet transplantation is a promising strategy for β‐cell replacement therapy in the treatment of Type 1 Diabetes. However, several obstacles hinder the long‐term efficacy of this therapy. A major challenge is the scarcity of donor organs. During the isolation process, islets are disconnected from their extracellular matrix (ECM) and vasculature, leading to significant loss due to anoikis and hypoxia. Additionally, inflammatory and rejection reactions further compromise islet survival and engraftment success. Extensive efforts are being made to improve the efficacy of islet transplantation. These strategies include promoting revascularization and ECM support through bioengineering techniques, exploring alternative sources of insulin‐secreting cells, and providing immunomodulation for the graft. Despite these advancements, a significant gap remains in integrating these strategies into a cohesive approach that effectively replicates the native endocrine environment. Specifically, the lack of comprehensive methods to address both the structural and functional aspects of the endocrine niche limits reproducibility and clinical translation. Therefore, bioengineering an endocrine pancreas must aim to recreate the endocrine niche to achieve lifelong efficacy and insulin independence. This review discusses various strategies developed to produce the building blocks for generating a vascularized, immune‐protected insulin‐secreting construct, emphasizing the importance of the endocrine niche's composition and function.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Laboratory of Tissue Engineering and Organ Regeneration, Department of Surgery, University of Geneva, Geneva, Switzerland.
- Cell Isolation and Transplantation Center, Department of Surgery, Geneva University Hospitals and University of Geneva, Geneva, Switzerland.
- Faculty Diabetes Center, University of Geneva Medical Center, University of Geneva, Geneva, Switzerland.
- Institute of Medical and Public Health Research, Ilia State University, Tbilisi, Georgia.
ORCID-Profile: Laura Mar Fonseca, Fanny Lebreton, Ekaterine Berishvili
Förderung
- Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung
- Breakthrough T1D International
- Horizon 2020 Framework Programme
Zitieren
APA
Fonseca, L. M., Krause, N., Lebreton, F., & Berishvili, E. (2025). Recreating the Endocrine Niche: Advances in Bioengineering the Pancreas. Artificial Organs. https://doi.org/10.1111/aor.14950
Vancouver
Fonseca LM, Krause N, Lebreton F, Berishvili E. Recreating the Endocrine Niche: Advances in Bioengineering the Pancreas. Artificial Organs. 2025. doi:10.1111/aor.14950
BibTeX
@article{Fonseca2025,
author = {Fonseca, Laura Mar and Krause, Nicerine and Lebreton, Fanny and Berishvili, Ekaterine},
title = {Recreating the Endocrine Niche: Advances in Bioengineering the Pancreas},
journal = {Artificial Organs},
year = {2025},
doi = {10.1111/aor.14950}
}
EUVIMED